Showing results (2391-2400 of 3,888) with videos related to
Sort By:
Pageof 389
Cancer Biology & Therapy|October 20, 2009
Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinomaHirotake Takai, Motohki Ashihara, Takahiro Ishiguro, et al.Cancer Biology & Therapy|March 5, 2010
Phase I trial of ATRA-IV and Depakote in patients with advanced solid tumor malignanciesKevin A David, Nigel P Mongan, Christopher Smith, et al.Cancer Biology & Therapy|March 5, 2010
Stathmin/oncoprotein 18, a microtubule regulatory protein, is required for survival of both normal and cancer cell lines lacking the tumor suppressor, p53Bruce K Carney, Lynne CassimerisCancer Biology & Therapy|March 10, 2010
Antitumor effects of EMAP II against pancreatic cancer through inhibition of fibronectin-dependent proliferationRoderich E Schwarz, Niranjan Awasthi, Srivani Konduri, et al.Cancer Biology & Therapy|May 1, 2018
PI3K/AKT/mTOR pathway inhibitors inhibit the growth of melanoma cells with mTOR H2189Y mutations in vitroXiaowen Wu, Jiayi Yu, Junya Yan, et al.Cancer Biology & Therapy|June 28, 2018
A retrospective case study of sunitinib treatment in three patients with Von Hippel-Lindau diseaseGang Yuan, Qiuli Liu, Dali Tong, et al.Cancer Biology & Therapy|July 17, 2018
The transcription-independent mitochondrial cell death pathway is defective in non-transformed cells containing the Pro47Ser variant of p53Anna Budina-Kolomets, Thibaut Barnoud, Maureen E MurphyCancer Biology & Therapy|January 21, 2010
Stromal-epithelial interactions are responsible for prostate tumor progression through an androgen-related mechanismHaveesh Sharma, Tristan M Sissung, Heather Pressler, et al.Cancer Biology & Therapy|May 13, 2017
miR-337 can be a key negative regulator in melanomaWanan Xiao, Enyang Yao, Wei Zheng, et al.Cancer Biology & Therapy|April 29, 2017
Expression of miR-23a by apoptotic regulators in human cancer: A reviewRabih Roufayel, Seifedine KadryPageof 389